サマリー

内腔縫合装置の世界市場は、2022年の7800万米ドルから2027年には1億3900万米ドルに達し、CAGR12.0％で推移すると予測されます。この市場の成長は、肥満手術の需要の高まり、手術件数の増加、消化器系疾患の有病率の上昇に大きく起因していると思われます。

"消化器外科分野は、予測期間中に最も高いCAGRを記録すると予想される"
用途に基づき、世界の内腔縫合装置市場は、肥満手術、胃腸手術、胃食道逆流症手術、その他の手術に区分されます。消化器外科分野は、予測期間中に最も高い成長を記録すると予想されます。これは主に、世界的に消化器癌の症例数が増加していることに起因します。


"内腔縫合器エンドユーザー市場では、予測期間中、外来診療所セグメントが最も高い成長を遂げる"
エンドユーザーに基づいて、内腔縫合装置市場は、病院、外来手術センター、診療所、その他のエンドユーザーに区分されます。外来手術センター部門は、予測期間中に最も高い成長を記録すると予想されます。これは、費用対効果の高い治療が提供されるため、外来診療の場で治療を受ける採用が増加していることに起因している可能性があります。



「APACは、予測期間中に最も高い成長を目撃する。
アジア太平洋地域は、2022-2027年の予測期間中に最も高いCAGRで成長すると予想されます。インド、中国、日本などの高成長市場の存在、中国やインドにおける医療産業の急速な発展、病院数の増加、一人当たり所得の上昇、医療インフラの増加、GI癌の負担増、健康に対する意識の高まりなどが、アジア太平洋地域における内腔縫合器市場の成長を促進する主要因として期待されています。

主な参加企業の内訳は以下の通りです。
- 企業タイプ別：Tier 1-35%、Tier 2-45%、Tier 3-20
- 役職別：Cレベル-35％、ディレクターレベル-25％、その他-40
- 地域別：北米-40%、欧州-30%、アジア太平洋-20%、中南米-5%、中東・アフリカ-5


内腔縫合器市場の主要企業

内腔縫合器市場の主要プレイヤーは、Apollo Endosurgery, Inc.（米国）、Johnson & Johnson（米国）、Medtronic Plc（アイルランド）、Cook Group Incorporated（米国）、USGI Medical（米国）、Ovesco Endoscopy AG（ドイツ）、Endo Tools Therapeutics S.A（ベルギー）、ErgoSuture（米国）、Sutrue Ltd.（米国）となっています。(英国)があります。

調査対象範囲
当レポートでは、内腔縫合器市場を分析し、市場規模や今後の成長可能性を、用途やエンドユーザーなどの様々なセグメントに基づいて推定することを目的としています。また、市場で入手可能な様々な内腔縫合器具の製品ポートフォリオマトリックスも掲載しています。また、同市場の主要企業の競争力分析も行っており、企業プロファイル、製品提供、主要な市場戦略などを掲載しています。

本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいては市場のより重要なシェアを獲得するのに役立つことでしょう。本レポートを購入された企業は、以下の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。

本レポートでは、以下のポイントについて考察しています。
- 市場浸透度。内腔縫合器市場の上位企業が提供する製品ポートフォリオに関する包括的な情報。本レポートでは、この市場をアプリケーション別、エンドユーザー別に分析しています。
- 製品の強化/革新。内腔縫合器具の世界市場における今後の動向と製品の発売に関する詳細な洞察。
- 市場開発。アプリケーション別、エンドユーザー別の有利な新興市場に関する包括的な情報を提供します。
- 市場の多様化。新製品や製品の強化、成長地域、最近の開発、世界の内腔縫合装置市場における投資に関する詳細な情報。
- 競争力の評価。内腔縫合器具の世界市場における主要企業の市場シェア、成長戦略、製品提供、競争上のリーダーシップマッピング、能力に関する詳細な評価。

ページTOPに戻る

目次

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.2.2 MARKETS COVERED 21
FIGURE 1 ENDOLUMINAL SUTURING DEVICES MARKET SEGMENTATION 21
1.2.3 YEARS CONSIDERED 21
1.3 CURRENCY CONSIDERED 22
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 22
1.4 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.2 RESEARCH DESIGN 23
FIGURE 2 ENDOLUMINAL SUTURING DEVICES MARKET: RESEARCH DESIGN 23
2.2.1 SECONDARY RESEARCH 24
2.2.1.1 Key data from secondary sources 25
2.2.2 PRIMARY DATA 25
FIGURE 3 PRIMARY SOURCES 26
2.2.2.1 Key data from primary sources 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
2.3 MARKET SIZE ESTIMATION 28
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 28
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 29
FIGURE 7 TOP-DOWN APPROACH 29
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 9 CAGR PROJECTIONS 31
2.4 DATA TRIANGULATION APPROACH 32
FIGURE 10 DATA TRIANGULATION METHODOLOGY 32
2.5 MARKET SHARE ESTIMATION 33
2.6 ASSUMPTIONS 33
2.7 LIMITATIONS 33
2.7.1 METHODOLOGY-RELATED LIMITATIONS 33
2.7.2 SCOPE-RELATED LIMITATIONS 34
2.8 RISK ASSESSMENT 34
TABLE 2 RISK ASSESSMENT: ENDOLUMINAL SUTURING DEVICES MARKET 34
 
3 EXECUTIVE SUMMARY 35
FIGURE 11 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 35
FIGURE 12 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 36
FIGURE 13 GEOGRAPHIC SNAPSHOT OF ENDOLUMINAL SUTURING DEVICES MARKET 37
4 PREMIUM INSIGHTS 38
4.1 ENDOLUMINAL SUTURING DEVICES MARKET OVERVIEW 38
FIGURE 14 RISING NUMBER OF SURGICAL PROCEDURES PERFORMED TO DRIVE GROWTH 38
4.2 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION AND COUNTRY (2021) 39
FIGURE 15 GASTROINTESTINAL SURGERIES ACCOUNTED FOR LARGEST SHARE
OF ASIA PACIFIC MARKET IN 2021 39
4.3 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40
4.4 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION (2020–2027) 41
FIGURE 17 NORTH AMERICA TO DOMINATE ENDOLUMINAL SUTURING DEVICES MARKET IN 2027 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 18 ENDOLUMINAL SUTURING DEVICES MARKET: KEY DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing number of surgical procedures worldwide 43
TABLE 3 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2020 43
5.2.1.2 Rising prevalence of gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases 44
TABLE 4 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020 45
TABLE 5 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020 45
5.2.1.3 Favorable reimbursement scenario 45
5.2.2 RESTRAINTS 46
5.2.2.1 Presence of alternative wound care management products 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 High-growth opportunities in emerging markets 46
TABLE 6 AVERAGE SURGICAL PROCEDURE COSTS (2021) 46
5.2.3.2 Increasing adoption of outpatient surgeries 47
5.2.4 CHALLENGES 47
5.2.4.1 Shortage of skilled personnel 47
 
5.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 48
TABLE 7 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 48
5.4 REGULATORY ANALYSIS 49
5.4.1 NORTH AMERICA 49
5.4.1.1 US 49
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION 49
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.4.1.2 Canada 50
TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.4.2 EUROPE 50
5.4.3 ASIA PACIFIC 51
5.4.3.1 Japan 51
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51
5.4.3.2 China 51
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 52
5.4.3.3 India 52
5.5 PORTER’S FIVE FORCES ANALYSIS 52
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 52
5.5.1 THREAT FROM NEW ENTRANTS 53
5.5.2 THREAT FROM SUBSTITUTES 53
5.5.3 BARGAINING POWER OF SUPPLIERS 53
5.5.4 BARGAINING POWER OF BUYERS 54
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.6 VALUE CHAIN ANALYSIS 54
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 55
5.7 INDUSTRY TRENDS 55
5.7.1 MINIMALLY INVASIVE SURGERY 55
5.8 TECHNOLOGY ANALYSIS 56
5.8.1 ROBOTIC SUTURING SYSTEMS 56
5.9 ECOSYSTEM ANALYSIS 56
FIGURE 20 SURGICAL SUTURES MARKET: ECOSYSTEM MAP (2021) 56
5.10 PATENT ANALYSIS 57
5.10.1 PATENT PUBLICATION TRENDS FOR ENDOLUMINAL SUTURING DEVICES 57
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2022) 57
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 57
FIGURE 22 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ENDOLUMINAL SUTURING DEVICES (JANUARY 2011–JULY 2022) 58
FIGURE 23 TOP APPLICANT JURISDICTIONS FOR ENDOLUMINAL SUTURING DEVICE PATENTS (JANUARY 2011–JULY 2022) 59
TABLE 14 LIST OF PATENTS IN ENDOLUMINAL SUTURING DEVICES MARKET,
2020–2022 59
6 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION 61
6.1 INTRODUCTION 62
TABLE 15 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 62
6.2 BARIATRIC SURGERY 62
6.2.1 GROWING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH 62
TABLE 16 NUMBER OF BARIATRIC SURGERIES PERFORMED GLOBALLY (2018) 63
TABLE 17 US: NUMBER OF BARIATRIC SURGERIES, 2011–2020 64
TABLE 18 ENDOLUMINAL SURGICAL DEVICES MARKET FOR BARIATRIC SURGERY,
BY COUNTRY, 2020–2027 (USD THOUSAND) 64
6.3 GASTROINTESTINAL SURGERY 65
6.3.1 GROWING BURDEN OF COLON CANCER TO INCREASE DEMAND FOR GASTROINTESTINAL SURGERY 65
TABLE 19 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021 66
TABLE 20 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND) 67
6.4 GASTROESOPHAGEAL REFLUX DISEASE SURGERY 67
6.4.1 IMPROVING DIETS AND LIFESTYLE CHANGES TO RESTRAIN MARKET GROWTH 67
TABLE 21 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND) 68
6.5 OTHER SURGERIES 68
TABLE 22 ENDOLUMINAL SURGICAL DEVICES MARKET FOR OTHER SURGERIES,
BY COUNTRY, 2020–2027 (USD THOUSAND) 69
7 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER 70
7.1 INTRODUCTION 71
TABLE 23 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD MILLION) 71
7.2 HOSPITALS 71
7.2.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO PROPEL MARKET GROWTH 71
TABLE 24 NUMBER OF HOSPITALS, BY COUNTRY, 2010–2021 72
TABLE 25 ENDOLUMINAL SUTURING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD THOUSAND) 73
7.3 CLINICS 73
7.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS—
KEY ADVANTAGES DRIVING MARKET GROWTH 73
TABLE 26 ENDOLUMINAL SUTURING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD THOUSAND) 74
7.4 AMBULATORY SURGERY CENTERS 74
7.4.1 COST-EFFECTIVE TREATMENTS IN AMBULATORY CENTERS TO DRIVE DEMAND FOR THESE FACILITIES 74
TABLE 27 ENDOLUMINAL SUTURING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD THOUSAND) 75
7.5 OTHER END USERS 76
TABLE 28 ENDOLUMINAL SUTURING DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD THOUSAND) 77
8 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION 78
8.1 INTRODUCTION 79
FIGURE 24 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2021) 79
TABLE 29 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 80
8.2 NORTH AMERICA 80
TABLE 30 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 80
FIGURE 25 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT 81
TABLE 31 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 82
TABLE 32 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 82
TABLE 33 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 83
8.2.1 US 83
8.2.1.1 US to dominate North American endoluminal suturing devices market during forecast period 83
TABLE 34 US: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 84
TABLE 35 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 84
TABLE 36 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 85
8.2.2 CANADA 85
8.2.2.1 Increasing volume of surgeries to fuel demand for endoluminal suturing devices in Canada 85
TABLE 37 CANADA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS,
AND FIVE-YEAR PREVALENCE (2020) 86
TABLE 38 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 86
TABLE 39 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 86
8.3 EUROPE 87
TABLE 40 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 87
TABLE 41 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY,
2020–2027 (USD THOUSAND) 87
TABLE 42 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 88
TABLE 43 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 88
8.3.1 GERMANY 89
8.3.1.1 High penetration of health insurance makes Germany largest market for endoluminal suturing devices in Europe 89
TABLE 44 GERMANY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 89
TABLE 45 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 90
TABLE 46 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 90
8.3.2 FRANCE 91
8.3.2.1 Well-established healthcare system and growing procedural volume boost market growth 91
TABLE 47 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 91
TABLE 48 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 92
8.3.3 UK 92
8.3.3.1 Growing volume of hernia repair and bowel cancer surgeries will stimulate market growth 92
TABLE 49 UK: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 92
TABLE 50 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 93
TABLE 51 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 93
8.3.4 ITALY 94
8.3.4.1 Initiatives to build awareness about digestive health to increase adoption of endoluminal suturing devices 94
TABLE 52 ITALY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 94
TABLE 53 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 95
TABLE 54 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 95
8.3.5 SPAIN 95
8.3.5.1 Growing healthcare budget to drive growth in Spain 95
TABLE 55 SPAIN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 96
TABLE 56 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 96
TABLE 57 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 97
8.3.6 REST OF EUROPE 97
TABLE 58 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 98
TABLE 59 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 98
 
8.4 ASIA PACIFIC 99
TABLE 60 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 99
FIGURE 26 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT 100
TABLE 61 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 101
TABLE 62 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 101
TABLE 63 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 102
8.4.1 JAPAN 102
8.4.1.1 Strong healthcare system in Japan supports growth of endoluminal suturing devices market 102
TABLE 64 JAPAN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 103
TABLE 65 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 103
TABLE 66 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 104
8.4.2 CHINA 104
8.4.2.1 Growing number of hospitals and increased prevalence of obesity to propel growth in China 104
TABLE 67 CHINA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 105
TABLE 68 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 105
TABLE 69 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 105
8.4.3 INDIA 106
8.4.3.1 Increasing prevalence of gastrointestinal disorders and favorable government support to drive market in India 106
TABLE 70 INDIA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 106
TABLE 71 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND) 107
TABLE 72 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND) 107
8.4.4 REST OF ASIA PACIFIC 108
TABLE 73 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 108
TABLE 74 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 109
8.5 LATIN AMERICA 109
8.5.1 GROWING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES TO PROPEL MARKET 109
TABLE 75 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 110
TABLE 76 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020) 110
TABLE 77 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 110
TABLE 78 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND) 111
8.6 MIDDLE EAST & AFRICA 111
8.6.1 MIDDLE EAST & AFRICA—SMALLEST REGIONAL MARKET FOR ENDOLUMINAL SUTURING DEVICES 111
TABLE 79 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020) 111
TABLE 80 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND) 112
TABLE 81 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND) 112
9 COMPETITIVE LANDSCAPE 113
9.1 OVERVIEW 113
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 113
9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 113
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOLUMINAL SUTURING DEVICES MARKET 114
9.4 MARKET SHARE ANALYSIS 114
FIGURE 28 ENDOLUMINAL SUTURING DEVICES MARKET SHARE, BY KEY PLAYER, 2021 114
TABLE 82 ENDOLUMINAL SUTURING DEVICES MARKET: DEGREE OF COMPETITION 115
9.5 COMPETITIVE BENCHMARKING 116
TABLE 83 ENDOLUMINAL SUTURING DEVICES MARKET: COMPETITIVE BENCHMARKING 116
9.6 COMPANY FOOTPRINT 117
TABLE 84 FOOTPRINT OF COMPANIES IN ENDOLUMINAL SUTURING DEVICES MARKET 117
9.6.1 APPLICATION FOOTPRINT 117
TABLE 85 APPLICATION FOOTPRINT OF COMPANIES 117
9.6.2 END-USER FOOTPRINT 118
TABLE 86 END-USER FOOTPRINT OF COMPANIES 118
9.6.3 REGIONAL FOOTPRINT 118
TABLE 87 REGIONAL FOOTPRINT OF COMPANIES 118
9.7 COMPANY EVALUATION QUADRANT 119
9.7.1 STARS 119
9.7.2 EMERGING LEADERS 119
9.7.3 PERVASIVE PLAYERS 119
9.7.4 PARTICIPANTS 119
FIGURE 29 ENDOLUMINAL SUTURING DEVICES MARKET: COMPANY EVALUATION QUADRANT (2021) 120
9.8 COMPETITIVE SCENARIO 121
9.8.1 PRODUCT LAUNCHES 121
TABLE 88 PRODUCT LAUNCHES (JANUARY 2019–JULY 2022) 121
9.8.2 OTHER DEVELOPMENTS 121
TABLE 89 OTHER DEVELOPMENTS (JANUARY 2019–JULY 2022) 121
10 COMPANY PROFILES 122
10.1 KEY PLAYERS 122
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 APOLLO ENDOSURGERY, INC. 122
TABLE 90 APOLLO ENDOSURGERY, INC.: BUSINESS OVERVIEW 122
FIGURE 30 APOLLO ENDOSURGERY, INC.: COMPANY SNAPSHOT (2021) 123
10.1.2 JOHNSON & JOHNSON (ETHICON, INC.) 125
TABLE 91 JOHNSON & JOHNSON: BUSINESS OVERVIEW 125
FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 126
10.1.3 MEDTRONIC PLC 128
TABLE 92 MEDTRONIC, INC.: BUSINESS OVERVIEW 128
FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 129
10.1.4 COOK GROUP INCORPORATED 131
TABLE 93 COOK GROUP INCORPORATED: BUSINESS OVERVIEW 131
10.1.5 USGI MEDICAL 133
TABLE 94 USGI MEDICAL: BUSINESS OVERVIEW 133
10.1.6 OVESCO ENDOSCOPY AG 135
TABLE 95 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW 135
10.1.7 ENDO TOOLS THERAPEUTICS S.A. 136
TABLE 96 ENDO TOOLS THERAPEUTICS S.A.: BUSINESS OVERVIEW 136
10.1.8 ERGOSUTURE 137
TABLE 97 ERGOSUTURE: BUSINESS OVERVIEW 137
10.1.9 SUTRUE LTD. 138
TABLE 98 SUTRUE LTD.: BUSINESS OVERVIEW 138
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 139
11.1 INSIGHTS FROM INDUSTRY EXPERTS 139
11.2 DISCUSSION GUIDE 140
11.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
11.4 CUSTOMIZATION OPTIONS 145
11.5 RELATED REPORTS 145
11.6 AUTHOR DETAILS 146